Yarbrough Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,898
Closed -$4.64M – 87
2026
Q2
$4.64M Hold
11,898
– – 0.14% 55
2026
Q1
$5.63M Hold
11,898
– – 0.2% 49
2025
Q4
$5.55M Hold
11,898
– – 0.17% 50
2025
Q3
$5.07M Hold
11,898
– – 0.16% 56
2025
Q2
$4.56M Hold
11,898
– – 0.16% 55
2025
Q1
$4.11M Hold
11,898
– – 0.18% 54
2024
Q4
$3.57M Hold
11,898
– – 0.14% 60
2024
Q3
$4.84M Hold
11,898
– – 0.2% 49
2024
Q2
$3.82M Hold
11,898
– – 0.16% 55
2024
Q1
$3.97M Hold
11,898
– – 0.17% 55
2023
Q4
$3.22M Hold
11,898
– – 0.17% 63
2023
Q3
$2.93M Hold
11,898
– – 0.17% 62
2023
Q2
$3.61M Hold
11,898
– – 0.2% 58
2023
Q1
$3.14M Hold
11,898
– – 0.26% 62
2022
Q4
$2.86M Hold
11,898
– – 0.23% 59
2022
Q3
$2.19M Hold
11,898
– – 0.17% 65
2022
Q2
$2M Hold
11,898
– – 0.15% 66
2022
Q1
$2.98M Hold
11,898
– – 0.17% 64
2021
Q4
$3.06M Buy
+11,898
New +$2.91M 0.16% 67

Other funds holding HCA

Yarbrough Capital's HCA Position: Q3 2026 in Review

Yarbrough Capital sold out of HCA Healthcare (HCA) in Q3 2026, closing a stake of 11,898 shares — an estimated $4.64M sold.

Yarbrough Capital first reported a position in HCA in Q4 2021 and held it in 19 quarters. The position peaked at $5.63M in Q1 2026. 772 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Yarbrough Capital reported no remaining HCA Healthcare position as of Q3 2026 after selling out during the quarter.
  • Yarbrough Capital sold 11,898 HCA Healthcare shares in Q3 2026, an estimated $4.64M.
  • Yarbrough Capital first reported a position in HCA Healthcare in Q4 2021 and held it in 19 quarters.
  • Yarbrough Capital's HCA Healthcare position peaked at $5.63M in Q1 2026.
  • 772 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Yarbrough Capital's 13F filing for Q3 2026, filed 19 Oct 2026.